Aberdeen Group’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Hold |
891,448
| – | – | ﹤0.01% | 810 |
|
|
2025
Q1 | $1.23M | Buy |
891,448
+7,744
| +0.9% | +$10.7K | ﹤0.01% | 800 |
|
|
2024
Q4 | $2.69M | Buy |
883,704
+512,049
| +138% | +$1.56M | 0.01% | 729 |
|
|
2024
Q3 | $1.85M | Buy |
371,655
+79,511
| +27% | +$396K | ﹤0.01% | 760 |
|
|
2024
Q2 | $1.71M | Buy |
292,144
+92,144
| +46% | +$539K | ﹤0.01% | 769 |
|
|
2024
Q1 | $1.59M | Hold |
200,000
| – | – | ﹤0.01% | 793 |
|
|
2023
Q4 | $1.17M | Buy |
+200,000
| New | +$1.17M | ﹤0.01% | 825 |
|